ERBB2 and breast carcinoma: Cellular delivery was assessed by complexing S‐PNA with lipofectamine, comparing the complex with the standard PNA oligomer in SKBR3 cells[50] (a human breast cancer cell line known to overexpress the HER2 gene product).